TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 106 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $342,000 | -20.8% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $432,000 | +2.1% | 4,000 | -20.0% | 0.00% | 0.0% |
| Q4 2018 | $423,000 | -14.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $492,000 | -14.9% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $578,000 | +17.0% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $494,000 | -5.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $524,000 | -6.9% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $563,000 | -20.3% | 5,000 | -20.6% | 0.00% | -20.0% |
| Q2 2017 | $706,000 | -3.9% | 6,300 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $735,000 | +10.9% | 6,300 | 0.0% | 0.01% | +20.0% |
| Q4 2016 | $663,000 | -11.7% | 6,300 | -7.4% | 0.01% | -16.7% |
| Q3 2016 | $751,000 | – | 6,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |